Adverse Drug Reaction Classification System

ADR Ontology
ADR Term Refractory cytopenia with unilineage dysplasia
ADR ID BADD_A06687
ADR Hierarchy
01      Blood and lymphatic system disorders
01.10      Leukaemias
01.10.04      Myelodysplastic syndromes
01.10.04.007      Refractory cytopenia with unilineage dysplasia
16      Neoplasms benign, malignant and unspecified (incl cysts and polyps)
16.01      Leukaemias
16.01.04      Myelodysplastic syndromes
16.01.04.007      Refractory cytopenia with unilineage dysplasia
Description A severe sometimes chronic anemia, usually macrocytic in type, that does not respond to ordinary antianemic therapy. [MeSH]
MedDRA Code 10072684
MeSH ID D000753
ADR Severity Grade (FAERS)
ADR Severity Grade (CTCAE) Not Available
Synonym
Anemia refractory | Refractory anaemia | Refractory anemia | Anaemia refractory | Refractory cytopenia with unilineage dysplasia | Anemia, Refractory | Refractory Anemia | Anemias, Refractory | Refractory Anemias
ADR Related Proteins
Protein Name UniProt AC TTD Target ID
Not AvailableNot AvailableNot Available
Drugs Leading to the ADR
Drug IDDrug NameADR Frequency (FAERS)ADR Severity Grade (FAERS)
BADD_D00194Azacitidine0.000139%
BADD_D01253Lenalidomide0.000453%
BADD_D01313Lomustine--
BADD_D01322Losartan0.000019%
BADD_D01653Paclitaxel0.000208%
BADD_D01933Ribavirin0.007095%
BADD_D01954Rivaroxaban0.000093%
The 1th Page    1    Total 1 Pages